Ceribell (CBLL) Gains from Investment Securities (2023 - 2024)
Ceribell's (CBLL) quarterly Gains from Investment Securities came in at $1.1 million in Q4 2024, up 523.7% on a QoQ basis from $173000.0 in Q3 2024.
Ceribell (CBLL) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Ceribell (CBLL) has 2 years of Gains from Investment Securities data on file, last reported at $1.1 million in Q4 2024.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $1.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $1.3 million (down 16.31% YoY) and the FY2024 annual result came in at $1.5 million, up 3216.67% from the prior year.
- Gains from Investment Securities rose to $1.1 million in Q4 2024, from $173000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.1 million in Q4 2024 to a low of $2000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Ceribell | 916.57 Mn | 787.31 Mn | 25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 242,000.00 |
| Jun 30, 2024 | 242,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |